Wound Care News

By Shelley Ducker, Alliance of Wound Care Stakeholders

Coverage trends indicate that wound patients are increasingly being denied access to important products/services/procedures – or are being limited in receiving them – because of restrictions in payer coverage policies. Many times, restrictions – or utilization parameters – are out of step with clinical guidelines and current clinical practice.

By Industry News

Toronto, Canada – February 13, 2020 – MolecuLight Inc., maker of a handheld fluorescence imaging device for real-time detection of bacteria in wounds, announced that the American Medical Association (AMA) has issued two new CPT category lll codes to enable a reimbursement pathway for point-of-care real-time fluorescence wound imaging for bacterial presence, location and load using the MolecuLight i:X® procedure.

By Industry News

Toronto, Canada – February 10, 2020 – University Hospitals Ahuja Medical Center (UH) is the first clinical setting in Ohio using special technology to identify harmful bacteria, leading to healing for patients suffering from chronic wounds.

The Alliance of Wound Care Stakeholders is excited to kick-off 2020 by tackling a critical issue with impact across the wound care community: what and how much clinical evidence do payers need to cover wound care products and procedures? At their April Wound Care Evidence Summit in Washington D.C., the Alliance will convene payers, policymakers, and regulators to address this question and collaboratively build solutions to common challenges.

By Industry News

Edison, NJ (January 21, 2020) – MTF Biologics, a global nonprofit tissue bank, today announced a partnership with Net Health, the a provider of cloud-based software for specialized care. The collaboration allows MTF Biologics to offer its wound care solutions through Net Health’s WoundExpert® EMR for use in outpatient wound care centers throughout the United States.

By Industry News

January 16, 2020 – Smith+Nephew, the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly reduced wound area, depth and volume compared to traditional negative pressure wound therapy (tNPWT) in patients with lower extremity ulcers.

By Industry News

Boston, Massachusetts (Jan. 15, 2020) ⁠— Healthy.io, the category creator of smartphone urinalysis and a leader in turning smartphone cameras into clinical-grade medical devices, announced the launch of its second product line, a digital wound management solution. The solution is an extension of Healthy.io’s clinical grade color recognition products in use by tens of thousands of people worldwide and helps healthcare professionals objectively assess chronic wounds and track their progress over time through a repeatable process. The solution was successfully registered with the U.S. Food and Drug Administration (FDA) in December 2019.

By Industry News

Atlantic Beach, FL – December 20, 2019 – Registration for the first virtual wound care conference, WoundCon, begins today. WoundCon will be held on April 2nd, 2020 and is hosted by Kestrel Health Information, Inc., the publisher of WoundSource, the leading wound care product reference guide for health care professionals. WoundCon will be free for all health care professionals and will offer multiple opportunities to earn CE/CME credits. The theme for the conference is “Learn today, apply tomorrow.”

By Industry News

Toronto, Canada – December 5, 2019 – MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time visualization of fluorescence in wounds, has received FDA 510(k) clearance for its i:X® handheld fluorescence imaging device for use in the detection of wounds containing bacteria. This FDA 510(k) clearance is an expansion of the original de novo clearance for the MolecuLight i:X platform, granted on August 14, 2018. The MolecuLight i:X enables real time point-of-care visualization of fluorescence in wounds and measures wounds and digitally records all images and area measurements. The i:X’s fluorescence image, when used in combination with clinical signs and symptoms (CSS), has been shown to increase the likelihood that clinicians can identify wounds containing bacterial loads of >104 CFU/g (colony-forming units per gram) as compared to examination of CSS alone. In addition to the 510(k), the MolecuLight i:X also has CE marking allowing for its sale in Europe and is approved by Health Canada for sale in Canada.

Edison, NJ (November 18, 2019) – MTF Biologics, a global nonprofit organization dedicated to saving and healing lives through organ and tissue donation, is introducing Leneva™ – Allograft Adipose Matrix and SomaGen™ Meshed – Allograft Dermal Matrix to its line of premier, innovative and effective wound care solutions. Developed to advance the treatment of complex surgical wounds, these first-to-market tissue forms aid in tissue reconstruction and wound closure by providing protective coverage and promoting tissue integration.